Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre for Neurology Studies (CNS) is a specialized clinical research organization and site based in Windsor, Ontario, Canada. Founded in 2006, the center focuses on conducting Phase II through Phase IV clinical trials for a wide range of neurological and psychiatric disorders. CNS collaborates with global pharmaceutical companies and biotechnology firms to evaluate the safety and efficacy of novel therapeutic agents. Key areas of research include Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, and Migraine. The facility provides comprehensive clinical trial management, including patient recruitment, neuroimaging, and cognitive testing. By bridging the gap between laboratory research and patient care, CNS plays a vital role in the clinical development of next-generation neurotherapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Neurology Studies.